Cardiovascular
Cardiovascular(心血管)
Cardiovascular
The cardiovascular system consists of the heart, blood and blood vessels. These organs form the 3 major closed circulation systems in the body, i.e., the pulmonary, coronary and systemic circulations. Cardiovascular disease includes heart disease, vascular diseases of the brain and kidney, and peripheral arterial diseases. Cardiovascular disease is the leading cause of death globally. Studies on cardiovascular regulation are important to provide a better understanding of this group of diseases and to help improve the corresponding treatment. read more
- Acute Phase Reactants(17)
- Angina(14)
- Arrhythmia(85)
- Atherosclerosis(93)
- Cardiogenesis
- Cardiomyopathy(5)
- Cholesterol Metabolism(46)
- Chronic Kidney Disease(18)
- Coagulation & Hemostasis(131)
- Coronary Artery Disease(8)
- Diabetic Nephropathy(10)
- Endothelium(35)
- Erythrocytes & Hemoglobin(53)
- Heart Failure(32)
- Hypertension(167)
- Hypotension(24)
- Lipoproteins(66)
- Myocardial Contractility(34)
- Myocardial Hypertrophy(22)
- Myocardial Infarction(64)
- Others(53)
- Serum Proteins(11)
- Smooth Muscle Cells(37)
- Storage & Transport(6)
- Stroke(53)
- Vasoconstriction(61)
- Thrombosis(58)
- Vasodilation(146)
Cardiovascular 相关产品(860)
- GC52310L-Arginine-13C6 (hydrochloride)CAS: 201740-91-2纯度: >95.00% / >98.50%
An internal standard for the quantification of L-arginine
- GC52318Oleic Acid-13C5CAS: 1255644-48-4纯度: >95.00%
An internal standard for the quantification of oleic acid
- GC523243-(3-Hydroxyphenyl)propionic Acid sulfateCAS: 86321-32-6纯度: >95.00%
A metabolite of certain phenols and glycosides
- GC52351Citrullinated α-Enolase (R8 + R14) (1-19)-biotin Peptide
A biotinylated and citrullinated α-enolase peptide
- GC52384NFAT Inhibitor (cell-permeable) (trifluoroacetate salt)纯度: >95.00%
A cell-permeable form of NFAT inhibitor
- GC52389Caveolin-1 (82-101) amide (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt)纯度: >95.00%
A synthetic peptide fragment of caveolin-1
- GC52390Spexin 1 (human, mouse, rat, bovine) (acetate)纯度: >98.00%
An endogenous peptide and agonist of GAL 2 and GAL 3
- GC52404γ-Glu-Phe (trifluoroacetate salt)纯度: >98.00%
A dipeptide with metabolism-altering activity
- GC52415Angiotensin A (trifluoroacetate salt)纯度: >98.00%
An AT 1 and AT 2 receptor agonist and active metabolite of angiotensin II
- GC52427Apelin-12 (human, mouse, rat, bovine) (acetate)纯度: >95.00%
An endogenous agonist of the APJ receptor
- GC60842FinerenoneCAS: 1050477-31-0纯度: >99.50%
非奈利酮（Finerenone；BAY 94-8862）是第三代选择性、具有口服活性的、非甾体类盐皮质激素受体 （MR）拮抗剂，IC 50 为18 nM。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC52310 | L-Arginine-13C6 (hydrochloride) | 201740-91-2 | >95.00% / >98.50% | |
An internal standard for the quantification of L-arginine | ||||
| GC52318 | Oleic Acid-13C5 | 1255644-48-4 | >95.00% | |
An internal standard for the quantification of oleic acid | ||||
| GC52324 | 3-(3-Hydroxyphenyl)propionic Acid sulfate | 86321-32-6 | >95.00% | |
A metabolite of certain phenols and glycosides | ||||
| GC52327 | Ciraparantag (trifluoroacetate salt) | - | >95.00% | |
An anticoagulant reversal agent | ||||
| GC52342 | P4pal10 (trifluoroacetate salt) | - | >98.00% | |
A PAR4 and FPR2 antagonist and an FFAR2 agonist | ||||
| GC52351 | Citrullinated α-Enolase (R8 + R14) (1-19)-biotin Peptide | - | - | |
A biotinylated and citrullinated α-enolase peptide | ||||
| GC52359 | ATX-100 | 2230647-37-5 | >98.00% | |
An ionizable cationic lipid | ||||
| GC52384 | NFAT Inhibitor (cell-permeable) (trifluoroacetate salt) | - | >95.00% | |
A cell-permeable form of NFAT inhibitor | ||||
| GC52388 | [D-Lys3]-GHRP-6 (trifluoroacetate salt) | - | >95.00% | |
An antagonist of GHS-R1a | ||||
| GC52389 | Caveolin-1 (82-101) amide (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt) | - | >95.00% | |
A synthetic peptide fragment of caveolin-1 | ||||
| GC52390 | Spexin 1 (human, mouse, rat, bovine) (acetate) | - | >98.00% | |
An endogenous peptide and agonist of GAL 2 and GAL 3 | ||||
| GC52400 | γ-Glu-Ala (trifluoroacetate salt) | - | >95.00% | |
A dipeptide | ||||
| GC52404 | γ-Glu-Phe (trifluoroacetate salt) | - | >98.00% | |
A dipeptide with metabolism-altering activity | ||||
| GC52415 | Angiotensin A (trifluoroacetate salt) | - | >98.00% | |
An AT 1 and AT 2 receptor agonist and active metabolite of angiotensin II | ||||
| GC52424 | Bradykinin Fragment (1-5) (trifluoroacetate salt) | - | >98.00% | |
A metabolite of bradykinin | ||||
| GC52427 | Apelin-12 (human, mouse, rat, bovine) (acetate) | - | >95.00% | |
An endogenous agonist of the APJ receptor | ||||
| GC52436 | TRAP-6 amide (trifluoroacetate salt) | - | >95.00% | |
A peptide PAR1 agonist | ||||
| GC52438 | CGRP (8-37) (mouse, rat) (trifluoroacetate salt) | - | >95.00% | |
A CGRP receptor antagonist | ||||
| GC52460 | tcY-NH2 (trifluoroacetate salt) | - | >98.00% | |
A peptide antagonist of PAR4 | ||||
| GC52478 | Telmisartan Acyl-β-D-Glucuronide (hydrate) | - | >95.00% | |
A major metabolite of telmisartan | ||||
| GC52497 | Lactosylceramide (porcine RBC) | - | >98.00% | |
A sphingolipid | ||||
| GC60120 | Danicamtiv | 1970972-74-7 | >99.00% | |
A cardiac-specific myosin activator | ||||
| GC60326 | Rivaroxaban D4 | 1132681-38-9 | - | |
An internal standard for the quantification of rivaroxaban | ||||
| GC60842 | Finerenone | 1050477-31-0 | >99.50% | |
非奈利酮（Finerenone；BAY 94-8862）是第三代选择性、具有口服活性的、非甾体类盐皮质激素受体 （MR）拮抗剂，IC 50 为18 nM。 | ||||